Bessemer Group’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.49M | Hold |
306,003
| – | – | 0.01% | 399 |
|
|
2025
Q1 | $3.64M | Hold |
306,003
| – | – | 0.01% | 392 |
|
|
2024
Q4 | $5.77M | Sell |
306,003
-50
| -0% | -$942 | 0.01% | 385 |
|
|
2024
Q3 | $6.88M | Buy |
306,053
+50
| +0% | +$1.12K | 0.01% | 359 |
|
|
2024
Q2 | $6.39M | Sell |
306,003
-51,284
| -14% | -$1.07M | 0.01% | 341 |
|
|
2024
Q1 | $5.25M | Hold |
357,287
| – | – | 0.01% | 380 |
|
|
2023
Q4 | $3.69M | Hold |
357,287
| – | – | 0.01% | 403 |
|
|
2023
Q3 | $2.81M | Hold |
357,287
| – | – | 0.01% | 421 |
|
|
2023
Q2 | $3.57M | Hold |
357,287
| – | – | 0.01% | 397 |
|
|
2023
Q1 | $3.17M | Hold |
357,287
| – | – | 0.01% | 393 |
|
|
2022
Q4 | $3.92M | Hold |
357,287
| – | – | 0.01% | 363 |
|
|
2022
Q3 | $4.66M | Buy |
357,287
+52,274
| +17% | +$681K | 0.01% | 330 |
|
|
2022
Q2 | $3.86M | Hold |
305,013
| – | – | 0.01% | 337 |
|
|
2022
Q1 | $4.27M | Buy |
305,013
+251
| +0.1% | +$3.52K | 0.01% | 263 |
|
|
2021
Q4 | $8.82M | Sell |
304,762
-23,857
| -7% | -$691K | 0.02% | 214 |
|
|
2021
Q3 | $9.85M | Buy |
328,619
+23,857
| +8% | +$715K | 0.02% | 220 |
|
|
2021
Q2 | $8.09M | Hold |
304,762
| – | – | 0.02% | 230 |
|
|
2021
Q1 | $9.48M | Buy |
+304,762
| New | +$9.48M | 0.02% | 230 |
|